Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

被引：0
作者：
Qiu-Feng He
Qiong-Fang Zhang
Da-Zhi Zhang
机构：
[1] Chongqing Medical University,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
Genotype 1 hepatitis C; Sofosbuvir; Ledipasvir; Ribavirin; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3108 / 3117
页数：9
相关论文
共 50 条
  • [41] Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan
    Chen, Jyh-Jou
    Lee, Pei-Lun
    Chiu, Hung-Chih
    Tung, Hung-Da
    Chiu, Yen-Cheng
    Cheng, Pin-Nan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (03) : 467 - 472
  • [42] Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan
    Butt, Nazish
    Reema, Sehrish
    Khan, M. Ali
    Abbasi, Amanullah
    Butt, Sehrish
    Khoso, Mohammad Masood
    Akbar, Ali
    Haleem, Farhan
    Mahesar, Ghulam Basit
    Fahad, Anoshia
    Qureshi, Talha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (04)
  • [43] Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
    Flamm, Steven
    Lawitz, Eric
    Borg, Brian
    Charlton, Michael
    Landis, Charles
    Reddy, K. Rajender
    Shiffman, Mitchell
    Alsina, Angel
    Chang, Charissa
    Ravendhran, Natarajan
    Hernandez, Candido
    Hezode, Christophe
    Scherbakovsky, Stacey
    Mercier, Renee-Claude
    Samuel, Didier
    VIRUSES-BASEL, 2023, 15 (10):
  • [44] Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection
    Bourliere, Marc
    Adhoute, Xavier
    Ansaldi, Christelle
    Oules, Valerie
    Benali, Souad
    Portal, Isabelle
    Castellani, Paul
    Halfon, Philippe
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (12) : 1483 - 1494
  • [45] Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan
    Akuta, Norio
    Sezaki, Hitomi
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (02) : 284 - 290
  • [46] Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
    Igarashi, Ataru
    Tang, Wentao
    Guerra, Ines
    Marie, Lucile
    Cure, Sandrine
    Lopresti, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 11 - 21
  • [47] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [48] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [49] Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis
    Sanai, Faisal M.
    Altraif, Ibrahim H.
    Alswat, Khalid
    AlZanbagi, Adnan
    Babatin, Mohamed A.
    AlMousa, Abdallah
    Almutairi, Nawaf H.
    Aljawad, Mohammed S.
    Alghamdi, Abdullah S.
    Aljumah, Abdulrahman A.
    Alalwan, Abduljaleel M.
    Al-Hamoudi, Waleed K.
    Assiri, Abdullah M.
    Dahlan, Yaser
    Alsahafi, Ashwaq
    Alothmani, Hammad S.
    Alsaleemi, Mohammed S.
    Mousa, Waleed A.
    Albenmousa, Ali
    Awny, Abdelrahman
    Albiladi, Haziz
    Abdo, Ayman A.
    Alghamdi, Hamdan
    JOURNAL OF INFECTION, 2018, 76 (06) : 536 - 542
  • [50] Ledipasvir plus Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis
    Liao, H. -T.
    Tan, P.
    Huang, J. -W.
    Yuan, K. -F.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1855 - 1863
12345